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Legionella micdadeiLegionnaires' disease is a severe respiratory disease that is estimated to cause between 8,000 and 18,000 hospi-
talizations each year, though the exact burden is unknown due to under-utilization of diagnostic testing. Al-
though Legionella pneumophila is the most common species detected in clinical cases (80-90%), other species
have also been reported to cause disease. However, little is known about Legionnaires' disease caused by these
non-pneumophila species. We designed a multiplex real-time PCR assay for detection of all Legionella spp. and
simultaneous speciﬁc identiﬁcation of four clinically-relevant Legionella species, L. anisa, L. bozemanii, L.
longbeachae, and L. micdadei, using 5′-hydrolysis probe real-time PCR. The analytical sensitivity for detection of
nucleic acid from each target species was ≤50 fg per reaction. We demonstrated the utility of this assay in spiked
human sputum specimens. This assay could serve as a tool for understanding the scope and impact of
non-pneumophila Legionella species in human disease.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Legionellae are Gram-negative bacteria ubiquitous in fresh water
and soil environments (Fields, 1996; Fields et al., 2002). Their ability
to inhabit and thrive inman-madewater systems, such as air condition-
ing units, cooling towers, hot tubs, and potable water systems creates a
potential hazard to human health (Fields, 1996; Fields et al., 2002;
Mercante and Winchell, 2015). At least half of the ~56 known species
of Legionella have been shown to cause disease in humans based on de-
tection in clinical specimens, but all species are thought to have patho-
genic potential (Fields et al., 2002; Muder and Yu, 2002). Inhalation of
aerosolized droplets containing Legionella may result in the develop-
ment of a severe form of pneumonia called Legionnaires' disease (LD)
or a milder, non-pneumonic form known as Pontiac fever (Fields et al.,
2002). According to estimates from the U.S. Centers for Disease Control
and Prevention, Legionella infections account for 8,000 to 18,000 hospi-
talizations each year (Fields et al., 2002; Marston et al., 1997). Legionella
has been implicated as the etiology in 3–14% of community-acquired
pneumonia (CAP) cases that require admission into the intensive careella pneumophila serogroup 1;
ction.
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ss article under the CC BY-NC-ND liceunit (File et al., 1998; Stout andYu, 1997;Waterer et al., 2001). Determi-
nation of the true burden of disease is impacted by limited use of diag-
nostic assays paired with the dearth of readily available standardized
diagnostic tests for non-pneumophila species.
L. pneumophila is the most commonly isolated organism from clinical
cases of LD in the United States, accounting for up to 90% of cases (Benin
et al., 2002; Yu et al., 2002). However, other serogroups and numerous
other species of Legionella have been implicated in clinical cases (Benin
et al., 2002; Muder and Yu, 2002; Yu et al., 2002). L. longbeachae,
L. micdadei, and L. bozemanii together account for the majority of non-
pneumophila LD cases, although the distribution may vary by geography
and patient population (Benin et al., 2002;McNally et al., 2000;Mercante
andWinchell, 2015; Muder and Yu, 2002; Yu et al., 2002). Though rarely
isolated as the primary pathogen from clinical cases of pneumonia,
L. anisa is frequently found along with L. pneumophila in hospital water
systems and could serve as a surrogate indicator for increased outbreak
risk (van der Mee-Marquet et al., 2006).
Bacterial culture directly from primary specimens remains the refer-
ence standard for detection of Legionella spp.; however, thismethod can
take severalweeks and is not feasible for identiﬁcation of acute infection
(Fields et al., 2002; Lee et al., 1993; Mercante and Winchell, 2015;
Muder and Yu, 2002). Although many serology-based tests are still
widely used, these suffer from limited speciﬁcity, lack of standardiza-
tion, and subjective nature of interpretation, and thus have not been
validated for diagnostic use (Mercante and Winchell, 2015). Further-
more, these assays are typically limited to detection of onlynse (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Primer and probe sequences.
Primer/Probe Name Sequence (5′→3′)
Pan-Legionella F primer GTACTAATTGGCTGATTGTCTTG
Pan-Legionella R primer TTCACTTCTGAGTTCGAGATGG
Pan-Legionella Probe FAM-CGCTATRGTCGCCAGGAAA-MGBNFQ
L. micdadei Probe Cy5-AGCTGATTGGTTAATAGCCCAATCGG-BHQ_2
L. anisa Probe HEX-CTCAACCTACGCAGAACTACTTGAGG-BHQ_1
L. bozemanii Probe ROX-TACGCCCATTCATCATGCAAACCAGTTT-BHQ_2
L. longbeachae Probe Quasar705-CTGAGTATCATGCCAATAATGCGCGC-BHQ_3
MGBNFQ, Minor Groove Binder non-ﬂuorescent quencher.
BHQ, Black Hole Quencher.
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tion with non-pneumophila species (Fields et al., 2002; Mercante and
Winchell, 2015; Muder and Yu, 2002). In comparison, PCR has been
shown to be a rapid and reliable method for detection of Legionella in
lower respiratory specimens and thus has emerged as a preferred diag-
nostic strategy (Diederen, 2008; Murdoch, 2003). One recent study
demonstrated that systematic screening of respiratory specimens from
patients with a clinical diagnosis of pneumonia improved case detec-
tion, particularly of milder cases (Murdoch et al., 2013). Still, PCR is
not widely and systematically implemented for diagnostic testing, and
detection of nucleic acid in a lower respiratory specimen has not yet
been recognized as sufﬁcient laboratory evidence for conﬁrmation of a
legionellosis case in the United States or Europe (Mercante and
Winchell, 2015).
The urinary antigen enzyme immunoassay (EIA) (Binax Legionella
Urinary Antigen EIA kit, Alere, Waltham, MA) is the primary method
used for diagnosis of Legionella infections in the United States and the
European Union, and a positive result using this method is widely con-
sidered conﬁrmatory laboratory evidence for diagnosis of legionellosis
(Benin et al., 2002; Den Boer and Yzerman, 2004; Dominguez et al.,
1998; Lepine et al., 1998; Mercante and Winchell, 2015). A critical lim-
itation of this method is that only the most prevalent species and
serogroup of Legionella, L. pneumophila serogroup 1 (Lp1), is detected
using this assay, thus precluding diagnosis of non-Lp1 and non-
pneumophila LD cases. Currently, PCR and sequencing of the mip and
16S genes are the primary molecular methods available for identiﬁca-
tion of non-pneumophila species (Cloud et al., 2000; Ratcliff et al.,
1998; Svarrer and Uldum, 2012), but these methods are typically only
performed at specialized reference laboratories and do not yield results
in a sufﬁciently rapid manner to inform patient clinical management.
In the current study, we describe a novel, rapid, single-tubemultiplex
real-time PCR assay for detection of all Legionella species and simulta-
neous speciﬁc identiﬁcation of clinically relevant non-pneumophila spe-
cies, including L. bozemanii, L. longbeachae, L. anisa and L. micdadei. We
demonstrate the utility of this assay for detection of the four targeted
Legionella species in mock human sputum specimens. This assay repre-
sents an extension of PCR methods for rapid detection of targeted non-
pneumophila Legionella species and could serve as a tool for understanding
the scope and impact of these species in human disease.
2. Materials and methods
2.1. Bacterial strains/isolates and nucleic acid extraction
Representative isolates of 50 available Legionella species (Supple-
mentary Table 1) and isolates from clinical specimens (n= 29) or envi-
ronmental samples (n = 34) were obtained from collections at the
Centers for Disease Control and Prevention (CDC) in Atlanta, GA.
Legionella were grown on buffered charcoal yeast extract agar, and
nucleic acid was extracted using the MagNA Pure Compact instrument
(Roche Applied Science, Indianapolis, IN) with total nucleic acid isola-
tion kit I according to manufacturer's instructions. All extracted nucleic
acid templates were normalized to 1 ng/μL.
2.2. Primer and probe design
Primers were designed manually or using Primer Express v3.0.1
(Thermo Fisher Scientiﬁc, Waltham, MA) based on alignment of the
23S-5S intergenic spacer region for all Legionella species provided by
Grattard et al. (Grattard et al., 2006). Primers were designed to anneal
speciﬁcally to a highly conserved region within the genome of all
Legionella species, and ﬁve unique 5′ hydrolysis probes were designed
within this ~200 basepair region for detection of any Legionella species
and speciﬁc identiﬁcation of L. anisa, L. bozemanii, L. longbeachae, and
L. micdadei. Sequences were aligned using Clustal Omega (http://
www.ebi.ac.uk/Tools/msa/clustalo/), and primers and probes werechosen for compatible melting temperatures, ideal G-C content, and min-
imal cross and self-complementarity. The ﬁnal selected sequences and
modiﬁcations are shown in Table 1. All oligonucleotides were
manufactured by Integrated DNA Technologies (Coralville, IA) with HPLC
puriﬁcation. All assays were initially tested for oligonucleotide dimeriza-
tion and cross-reactivity by testingwater as template (no template control
(NTC), n = 68).
2.3. Mastermix and run conditions
The ideal annealing temperature was determined by performing a
gradient PCR followed by a 1% ethidium bromide gel analysis. Various
primer and probe concentrations were tested to identify the optimal
ratio of oligonucleotides in the reaction mix. Each 25 μL multiplex reac-
tion contained 12.5 μL of PerfeCta® MultiPlex qPCR SuperMix (Quanta
Biosciences, Gaithersburg,MD), 150 nmeach of the forward and reverse
primer, 50 nmeach of the L. bozemanii (ROX) and L. anisa (HEX) probes,
25 nm each of the L. micdadei (Cy5) and L. longbeachae (Quas705)
probes, and 100 nm of the pan-Legionella (FAM) probe; 5 μL of normal-
ized template was used in each reaction. All reactions were run using
the Rotor-GeneQ instrument (Qiagen, Venlo, Netherlands)with the fol-
lowing cycling conditions: 5 minute denaturation at 95 °C followed by
40 cycles of 95 °C for 15 seconds and 60 °C for 60 seconds with data ac-
quisition in all ﬁve channels during the last step in each cycle.
2.4. Analytical sensitivity and speciﬁcity
The limit of detection (LOD) and assay efﬁciencywere determined for
each target, and values were compared between reactions in which the
mastermix included only the primers and the single probe speciﬁc for
the target being tested (singleplex) and reactions in which all ﬁve probes
were included (multiplex). The LOD was determined for each assay for-
mat by testing a series of six ten-fold dilutions of nucleic acid from each
targeted species (100 pg to 1 fg per reaction). The LOD was identiﬁed as
the lowest dilution at which ampliﬁcation was observed in at least 50%
of 10 replicates. Graphs were created using the Rotor-Gene Q analysis
software where log (DNA concentration) is on the x-axis and Crossing
threshold (Ct) value is on the y-axis, and reaction efﬁciencies were calcu-
lated based on the slope of the standard curve.
Pan-Legionella primers and probe were tested against 50 available
Legionella species, including multiple serogroups of each species, if ap-
plicable (n= 67, Supplementary Table 1). A panel of viral and bacterial
targets commonly found in lower respiratory tract specimens or envi-
ronmental sampleswere testedwith themultiplex assay at a concentra-
tion of 5 ng per reaction, including: Candida albicans, Chlamydophila
pneumoniae, Escherichia coli, Haemophilus inﬂuenzae, Klebsiella
pneumoniae, Moraxella catarrhalis, Neisseria meningitidis, Pseudomonas
aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, Strepto-
coccus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes,
Chlamydia psittaci, Lactobacillus plantarum, Neisseria elongata,
Ureaplasma urealyticum, human metapneumovirus, human
parainﬂuenza virus 1–4, Bordetella pertussis, Mycoplasma pneumoniae,
respiratory syncytial virus (RSV), human enterovirus, and rubella
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per reaction) was also tested.
2.5. Mock clinical specimen testing
Pooled human sputa (BioreclamationIVT, Hicksville, NY) were ho-
mogenized, incubated with 8 mM DTT (Thermo Fisher Scientiﬁc, Wal-
tham, MA) at room temperature for 30 minutes, and extracted as
described in Section 2.1. The pooled sputa were then screened for the
presence of Legionella species and other respiratory pathogens using
the TaqMan Array Card (TAC) (Thermo Fisher Scientiﬁc, Waltham,
MA) as previously described (Diaz et al., 2013). Culture stocks of
Legionellawere quantiﬁed bymeasuring optical density and comparing
to a standard curve. Quantiﬁed culture stocks of Legionella species were
spiked into 400 μL aliquots of the pooled human sputum or water in
order to simulate a clinical specimen containing 60, 40, 20, 10 or
1 CFU. Mock specimens were homogenized, pre-treated with dithio-
threitol (DTT), and extracted as described in Section 2.1 eluting 100 μL
from 400 μL. Mixed specimens were generated by spiking 40 CFU/mL
of L. pneumophila sg1 along with 20 CFU/mL of L. micdadei,
L. longbeachae, L. anisa, or L. bozemanii in order to assess the ability to de-
tect the less common species in the presence of excess L. pneumophila.
3. Results
3.1. Analytical sensitivity and speciﬁcity
All Legionella strains tested (n = 67, Supplementary Table 1) were
detected with the pan-species probe, and each representative isolateFig. 1. Ampliﬁcation efﬁciency of L. bozemanii (A), L. micdadei (B), L. longbeachae (C), and L. anis
best ﬁt is shown for both singleplex (grey) and multiplex (black) results. Data shown are ten rof L. anisa (n = 1), L. bozemanii (n = 2), L. longbeachae (n = 2), and
L. micdadei (n = 1) was detected in the appropriate channel corre-
sponding to the species-speciﬁc probe reporter dye. No cross-
reactivity was detected between the ﬁve probes (data not shown). No
ampliﬁcation was observed in any channel for other bacteria (n = 17)
or viruses (n= 6) tested (data not shown). The LODwas 10 fg per reac-
tion in both singleplex and multiplex reaction formats for L. bozemanii
(Fig. 1A) and L. micdadei (Fig. 1B). The LOD for L. longbeachae (Fig. 1C)
and L. anisa (Fig. 1D) was 50 fg in the singleplex reaction format and 10 fg
in the multiplex reaction. The LOD of each targeted species and
L. pneumophila using the pan-Legionella probewas 10 fg per reaction (Fig. 2).
3.2. Comparison of singleplex and multiplex assay efﬁciencies
Efﬁciency of each assay in the multiplex reaction was ≥94%, with
L. longbeachae having the highest efﬁciency (99%), followed by L.
micdadei (97%), L. anisa (96%), and L. bozemanii (94%) (Fig. 1). The reac-
tion efﬁciencies for L. anisa and L. bozemanii were higher in singleplex
thanmultiplex formatwhereas the L.micdadei and L. longbeachae assays
had slightly lower efﬁciencies in singleplex compared to multiplex
(Fig. 1). The efﬁciency of the pan-Legionella assay was ≥92% for each of
the ﬁve species tested (L. pneumophila, L. anisa, L. bozemanii,
L. longbeachae, and L. micdadei, Fig. 2).
3.3. Clinical and environmental isolate testing
Isolates from clinical specimens (n = 29) and environmental sam-
ples (n = 34) previously identiﬁed as L. micdadei (n = 10), L.
longbeachae (n = 12), L. anisa (n = 33), or L. bozemanii (n = 8) werea (D) in singleplex (grey circles) andmultiplex (white squares) reaction formats. A line of
eplicate reactions at each concentration.
Fig. 2. Limit of detection and efﬁciency of pan-Legionella probe detection in multiplex for L. anisa (yellow), L. bozemanii (orange), L. longbeachae (purple), L. micdadei (red) and
L. pneumophila (green). Data shown are ten replicate reactions at each concentration.
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cation of the pan-Legionella target region in the green channel, and
each targeted species displayed ampliﬁcation only in the channel corre-
sponding to the species-speciﬁc hydrolysis probe reporter dye. Results
of the multiplex PCR assay matched the species previously identiﬁed
by sequencing themip gene for all isolates.
3.4. Mock clinical specimen testing
Because primary clinical specimens for the targeted Legionella spp.
were lacking, mock specimens were generated by spiking varying con-
centrations of Legionella into pooled human sputa. Unspiked sputumdid
not contain Legionella spp. or any other organisms included in the test-
ing panel used here (data not shown). The specimen with the lowest
pathogen load (1 CFU) was detected for all four species, and the LOD
of each species was similar for nucleic acid extracted from spiked spu-
tum or water (Supplementary Table 2). The Ct values for detection of
each of the four targeted Legionella specieswere comparable in thepres-
ence or absence of excess L. pneumophila (data not shown).
4. Discussion
Diagnosis of legionellosis caused by non-pneumophila species is lim-
ited by the lack of available diagnostic methods for testing of clinical
specimens.We developed amultiplex real-time PCR assay for detection
of four clinically-relevant non-pneumophila species in a rapid and reli-
able manner. This assay enables detection of non-pneumophila
Legionella species without post-PCR processing or sequencing through
the use of one set of conserved primers along with ﬁve uniquely-labeled probes. Typically, multiplex real-time PCR assays require three
oligonucleotides (two primers and one probe) for each target in the re-
action. By targeting the 23S-5S intergenic spacer region, which has both
conserved and variable regions, we were able to amplify a single target
region in any Legionella spp. and detect ﬂuorescent signal from each
uniquely-labeled probe when bound to its species-speciﬁc target. This
approach minimizes the number of oligonucleotides in the reaction
mix, reducing the potential for cross-reactivity. This assay could be
modiﬁed to allow detection of other Legionella species of interest by de-
signing a species-speciﬁc hydrolysis probe within the target region and
re-evaluating the multiplex assay performance. This would allow for
customization of the assay to interrogate specimens for the most com-
mon non-pneumophila species, which may vary substantially between
different geographic regions or speciﬁc populations.
This assaywas designed to complement or augment existing screen-
ing recommendations, which include culture paired with the urinary
antigen test for Lp1 (Fields et al., 2002; Mercante and Winchell, 2015).
Increasing conﬁdence in the reliability of PCR for diagnosis of LD is likely
to result in a shift toward nucleic acid detection methods for Legionella.
To this end, we previously described a multiplex PCR assay to detect all
Legionella species, L. pneumophila, and L. pneumophila serogroup1
(Benitez and Winchell, 2013). The current assay was designed to be
used as a follow-up test for any isolate or specimen in which non-
pneumophila Legionellamay be identiﬁed. More recently, we reported
a multiplex real-time PCR high-resolution melt (PCR-HRM) assay to
be used for detection and typing of non-pneumophila Legionella spp., in-
cluding L. micdadei, L. bozemanii, L. dumofﬁi, L. longbeachae, L. feeleii,
L. anisa, L. parisiensis, L. tucsonensis serogroup (sg) 1 and 3, and
L. sainthelensis sg 1 and 2 isolates (Benitez and Winchell, 2016). While
Table 2
Detection of clinical and environmental Legionella isolates (n=63) with the multiplex assay in the current study.
Source Legionella spp. (n=63) L. micdadei (n=10) L. longbeachae (n=12) L. anisa (n=33) L. bozemanii (n=8)
Ct value Ct value Ct value Ct value Ct value
BAL 19.01 17.39 - - -
bronchial wash 20.19 18.01 - - -
sputum 20.11 18.22 - - -
BAL 20.7 18.67 - - -
lesion 21.44 18.85 - - -
bronchial wash 20.52 18.5 - - -
bronchial wash 19.97 17.84 - - -
environmental 19.45 17.44 - - -
environmental 20.48 17.95 - - -
environmental 19.5 17.36 - - -
human, unspeciﬁed 19.48 - 18.54 - -
bronchial wash 18.73 - 18.06 - -
BAL 20.47 - 19.79 - -
human, unspeciﬁed 21.86 - 21.05 - -
human, unspeciﬁed 20.96 - 20.43 - -
sputum 20.8 - 20.08 - -
bronchial wash 20.28 - 19.65 - -
bronchial wash 19.21 - 18.33 - -
bronchial wash 19.63 - 18.94 - -
BAL 22.26 - 21.33 - -
bronchial wash 21.25 - 20.47 - -
bronchial wash 19.35 - 18.82 - -
environmental 17.57 - - 20.32 -
environmental 18.77 - - 21.30 -
human, unspeciﬁed 20.00 - - 22.01 -
environmental 18.32 - - 20.58 -
environmental 18.42 - - 21.10 -
environmental 18.73 - - 21.14 -
environmental 18.23 - - 20.84 -
environmental 19.13 - - 21.20 -
bronchial wash 24.07 - - 26.95 -
environmental 20.02 - - 22.37 -
environmental 17.18 - - 19.65 -
environmental 16.34 - - 19.11 -
environmental 17.37 - - 20.75 -
environmental 19.47 - - 22.13 -
environmental 19.69 - - 21.61 -
environmental 16.89 - - 19.83 -
environmental 20.35 - - 21.91 -
environmental 19.91 - - 21.71 -
environmental 19.46 - - 21.69 -
environmental 19.21 - - 21.50 -
environmental 18.95 - - 21.01 -
environmental 20.18 - - 22.69 -
environmental 23.56 - - 24.60 -
environmental 18.32 - - 20.88 -
environmental 19.09 - - 19.93 -
environmental 21.86 - - 23.79 -
environmental 21.76 - - 25.10 -
environmental 19.88 - - 22.62 -
environmental 20.99 - - 24.82 -
environmental 16.94 - - 18.84 -
environmental 18.55 - - 21.12 -
environmental 19.46 - - 22.66 -
environmental 21.21 - - 24.31 -
bronchial wash 21.14 - - - 20.90
BAL 21.53 - - - 19.20
human, unspeciﬁed 21.92 - - - 18.81
BAL 19.79 - - - 20.51
BAL 20.74 - - - 17.78
BAL 24.18 - - - 19.52
BAL 21.26 - - - 19.81
BAL 20.93 - - - 18.65
Ct, Crossing threshold.
BAL, bronchoalveolar lavage.
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cies, it requires more specialized equipment, operator training, and a
longer run time compared to the multiplex hydrolysis probe assay de-
scribed here. Each method may be more suitable for different types of
laboratories in academic, clinical, and public health sectors depending
on the demand for Legionella test offerings and issues related tocompliance with regulations for patient testing, among other
laboratory-speciﬁc considerations. Implementation of real-time PCR as-
says such as these could be used to create a new diagnostic algorithm
that would facilitate identiﬁcation of LD cases caused by both
L. pneumophila and other less common, yet clinically signiﬁcant,
Legionella species.
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serogroups other than Lp1 are responsible for a substantial portion of
clinical cases, thus supporting the need for new diagnostic approaches
capable of broader detection of Legionella, such as the assay described
here. Among cases investigated by the U.S. CDC between 1980 and
1989 fromwhich an isolate was recovered from a clinical specimen, ap-
proximately 10% were caused by species other than L. pneumophila
(Marston et al., 1994). L. micdadei and L. bozemanii are frequently isolat-
ed during LD in immunocompromised patients (Doebbeling et al., 1989;
Fang et al., 1989; Humphreys et al., 1992; Knirsch et al., 2000; McNally
et al., 2000; Parry et al., 1985). L. longbeachae was the predominant
Legionella species identiﬁed among patients with severe pneumonia in
Thailand in 2004 (Phares et al., 2007) and is reported as a cause of LD
as often as L. pneumophila in Australia (Group NARW, 2013; Yu et al.,
2002). Incidence of LD due to L. longbeachae has also increased in coun-
tries where it was previously unreported, including Japan, Thailand,
Scotland and the Netherlands (Den Boer and Yzerman, 2004; Koide
et al., 2001; Paveenkittiporn et al., 2012; Pravinkumar et al., 2010), in
some places becoming even more prevalent than L. pneumophila
(Whiley and Bentham, 2011). In 2000 the U.S. CDC reported the ﬁrst
case of L. longbeachae transmission from potting soil occurring in the
United States (Centers for Disease Control and Prevention (CDC),
2000), but the true burden of disease attributable to L. longbeachae in
the United States is not known.
Augmentation of current diagnostic methods is needed in order to
fully appreciate the contribution of various Legionella species to the
global burden of LD. The replacement of culture-based methods with
the urinary antigen test as the primary diagnostic method may actually
mask the true incidence of LD cases caused by other serogroups of
L. pneumophila andnon-pneumophila species due to the limited speciﬁc-
ity of this test for detection of Lp1 only. Benin and colleagues reported a
decrease from28% to 4% in the frequency of isolates other than Lp1 from
1980 to 1998, during which time urine antigen testing emerged as the
primary diagnostic method (Benin et al., 2002). The importance of the
urine antigen test cannot be overstated; however, in cases of suspected
legionellosis in which this screening is negative, diagnostic testing
should be expanded to include non-pneumophila species.
Identiﬁcation of the species causing LD during an outbreak is crucial
to the protection of the public, particularly in the cases of Legionella pro-
liferation in hospital water systems. Public health ofﬁcials require both
environmental samples and clinical specimens in order to determine
the species and strain causing an LD outbreak. Our assay was designed
to include a probe for thedetection of L. anisa, as it is themost frequently
isolated species from hospital water systems, often found along with
L. pneumophila (van der Mee-Marquet et al., 2006). In some reported
outbreaks attributed to L. pneumophila based on detection in clinical
specimens, L. anisa has been the only Legionella species detected in the
potable water (van der Mee-Marquet et al., 2006). In these situations,
it is hypothesized that L. pneumophila was the minority population
and therefore was beyond the limit of detection of the testingmethods.
The abundance of L. anisa in water systemsmakes it a potentially useful
surrogate indicator of the presence of L. pneumophila. Additional testing
will be necessary to evaluate the utility of the current assay for detection
of L. anisa and other Legionella species in environmental samples.
This study has a few limitations, most notably the lack of available
primary clinical specimens to evaluate the new assay. We attempted
to closely approximate such specimens by introducing varying amounts
of Legionella into real human sputum. In addition, like all nucleic acid
ampliﬁcation tests, this assay cannot distinguish viable from non-
viable Legionella present in a sample. While the positive predictive
value for detection of Legionella in lower respiratory specimens by PCR is
very high, the detection of non-viable organisms could complicate the in-
terpretation of positive results obtained from environmental samples and
impact recommended remediation efforts. Further evaluation is needed to
fully deﬁne the performance characteristics of this assay for testing respi-
ratory specimens from LD cases as well as environmental samples.5. Conclusions
We developed a novel multiplex real-time PCR assay that allows de-
tection of all Legionella species while simultaneously distinguishing four
of themost commonly isolated non-pneumophila species. This assay ﬁlls
a need for detection of clinically relevant non-pneumophila species of
Legionella to complement existing methods for diagnosis of LD. Imple-
mentation of this technique could lead to improved detection of infec-
tions caused by non-pneumophila species of Legionella, contribute to
more rapid outbreak recognition and response, and improve our under-
standing of the scope and impact of non-pneumophila Legionella species
in human disease.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.diagmicrobio.2016.03.022.
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